Related Articles for PubMed (Select 17428320)

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.

Broeks A, Braaf LM, Huseinovic A, Nooijen A, Urbanus J, Hogervorst FB, Schmidt MK, Klijn JG, Russell NS, Van Leeuwen FE, Van 't Veer LJ.

Breast Cancer Res. 2007;9(2):R26.

PMID: 17428320 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study.

Mellemkjaer L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale AL, Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile RW, Andersson M, Thomas DC, Concannon P, Capanu M, Boice JD Jr; WECARE Study Collaborative Group, Bernstein JL.

Br J Cancer. 2008 Feb 26;98(4):728-33. Epub 2008 Feb 5.

PMID: 18253122 [PubMed - indexed for MEDLINE]

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; for the Institut Curie Breast Cancer Study Group.

Eur J Cancer. 2005 Oct;41(15):2304-11. Epub 2005 Sep 1.

PMID: 16140006 [PubMed - indexed for MEDLINE]

Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.

Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD Jr, Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Børresen-Dale AL, Concannon P, Thompson WD; WECARE study.

Breast Cancer Res. 2004;6(3):R199-214. Epub 2004 Mar 9.

PMID: 15084244 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Histopathological features of breast cancer in carriers of ATM gene variants.

Balleine RL, Murali R, Bilous AM, Farshid G, Waring P, Provan P, Byth K, Thorne H; kConFab Investigators, Kirk JA.

Histopathology. 2006 Nov;49(5):523-32.

PMID: 17064299 [PubMed - indexed for MEDLINE]

Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk.

Kaufmann WK, Filatov L, Oglesbee SE, Simpson DA, Lotano MA, McKeen HD, Sawyer LR, Moore DT, Millikan RC, Cordeiro-Stone M, Carey LA.

Carcinogenesis. 2006 Dec;27(12):2519-27. Epub 2006 Jun 15.

PMID: 16777992 [PubMed - indexed for MEDLINE]

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC.

JAMA. 2006 Mar 22;295(12):1379-88.

PMID: 16551709 [PubMed - indexed for MEDLINE]

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL.

J Natl Cancer Inst. 2003 Mar 19;95(6):448-57.

PMID: 12644538 [PubMed - indexed for MEDLINE]

Identification of women with an increased risk of developing radiation-induced breast cancer.

Cardis E, Hall J, Tavtigian SV.

Breast Cancer Res. 2007;9(3):106.

PMID: 17617928 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

10:

BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.

Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA.

JAMA. 1998 Mar 25;279(12):922-9.

PMID: 9544766 [PubMed - indexed for MEDLINE]

11:

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.

Broeks A, Russell NS, Floore AN, Urbanus JH, Dahler EC, van T Veer MB, Hagenbeek A, Noordijk EM, Crommelin MA, van Leeuwen FE, van T Veer LJ.

Int J Radiat Biol. 2000 May;76(5):693-8.

PMID: 10866292 [PubMed - indexed for MEDLINE]

12:

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.

Gynecol Oncol. 2005 May;97(2):457-67.

PMID: 15863145 [PubMed - indexed for MEDLINE]

13:

ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.

Brunet J, Gutiérrez-Enríquez S, Torres A, Bérez V, Sanjosé S, Galceran J, Izquierdo A, Menéndez JA, Gumà J, Borràs J.

Clin Genet. 2008 May;73(5):465-73. Epub 2008 Apr 2.

PMID: 18384426 [PubMed - indexed for MEDLINE]

14:

Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.

Lindeman GJ, Hiew M, Visvader JE, Leary J, Field M, Gaff CL, Gardner RJ, Trainor K, Cheetham G, Suthers G, Kirk J.

Breast Cancer Res. 2004;6(4):R401-7. Epub 2004 Jun 2.

PMID: 15217508 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

15:

Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility.

Johnson N, Fletcher O, Palles C, Rudd M, Webb E, Sellick G, dos Santos Silva I, McCormack V, Gibson L, Fraser A, Leonard A, Gilham C, Tavtigian SV, Ashworth A, Houlston R, Peto J.

Hum Mol Genet. 2007 May 1;16(9):1051-7. Epub 2007 Mar 6.

PMID: 17341484 [PubMed - indexed for MEDLINE]

16:

ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects.

Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):606-13.

PMID: 11849780 [PubMed - indexed for MEDLINE]

17:

Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.

Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE); Gene Etude Prospective Sein Ovaire (GENEPSO); Gen en Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland (GEO-HEBON); International BRCA1/2 Carrier Cohort Study (IBCCS) Collaborators' Group, Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, Antoniou AC, Wagner T, Simard J, Evans G, Peock S, Fricker JP, Nogues C, Van't Veer L, Van Leeuwen FE, Goldgar DE.

J Clin Oncol. 2006 Jul 20;24(21):3361-6. Epub 2006 Jun 26.

PMID: 16801631 [PubMed - indexed for MEDLINE]

18:

High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.

Shahedi K, Emanuelsson M, Wiklund F, Gronberg H.

Cancer. 2006 Mar 15;106(6):1237-42.

PMID: 16475207 [PubMed - indexed for MEDLINE]

19:

Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.

Gaffney DK, Hemmersmeier J, Holden J, Marshall J, Smith LM, Avizonis V, Tran T, Neuhausen SL.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):539-46.

PMID: 11173152 [PubMed - indexed for MEDLINE]